213 related articles for article (PubMed ID: 20110841)
1. Glucocorticoid induced osteopenia in cancellous bone of sheep: validation of large animal model for spine fusion and biomaterial research.
Ding M; Cheng L; Bollen P; Schwarz P; Overgaard S
Spine (Phila Pa 1976); 2010 Feb; 35(4):363-70. PubMed ID: 20110841
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid treatment of ovariectomized sheep affects mineral density, structure, and mechanical properties of cancellous bone.
Schorlemmer S; Gohl C; Iwabu S; Ignatius A; Claes L; Augat P
J Bone Miner Res; 2003 Nov; 18(11):2010-5. PubMed ID: 14606514
[TBL] [Abstract][Full Text] [Related]
3. The effects of glucocorticoid on microarchitecture, collagen, mineral and mechanical properties of sheep femur cortical bone.
Ding M; Danielsen CC; Overgaard S
J Tissue Eng Regen Med; 2012 Jun; 6(6):443-50. PubMed ID: 21751424
[TBL] [Abstract][Full Text] [Related]
4. Effects of glucocorticoid on BMD, micro-architecture and biomechanics of cancellous and cortical bone mass in OVX rabbits.
Liu X; Lei W; Wu Z; Cui Y; Han B; Fu S; Jiang C
Med Eng Phys; 2012 Jan; 34(1):2-8. PubMed ID: 21775186
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
[TBL] [Abstract][Full Text] [Related]
6. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
[TBL] [Abstract][Full Text] [Related]
7. Different changes of microarchitectures of cortical and cancellous bones in sheep femoral head after long-term glucocorticoid interventions.
Li YH; Gao FQ; Cheng LM; Zeng MD; Qiu QY; Ding M
Sci Rep; 2018 Jul; 8(1):9988. PubMed ID: 29968807
[TBL] [Abstract][Full Text] [Related]
8. The standardized creation of a lumbar spine vertebral compression fracture in a sheep osteoporosis model induced by ovariectomy, corticosteroid therapy and calcium/phosphorus/vitamin D-deficient diet.
Eschler A; Röpenack P; Herlyn PK; Roesner J; Pille K; Büsing K; Vollmar B; Mittlmeier T; Gradl G
Injury; 2015 Oct; 46 Suppl 4():S17-23. PubMed ID: 26542861
[TBL] [Abstract][Full Text] [Related]
9. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
[TBL] [Abstract][Full Text] [Related]
10. Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis.
Lill CA; Gerlach UV; Eckhardt C; Goldhahn J; Schneider E
Osteoporos Int; 2002 May; 13(5):407-14. PubMed ID: 12086352
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-treated sheep as a model for osteopenic trabecular bone in biomaterials research.
Augat P; Schorlemmer S; Gohl C; Iwabu S; Ignatius A; Claes L
J Biomed Mater Res A; 2003 Sep; 66(3):457-62. PubMed ID: 12918027
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):21-7. PubMed ID: 16637226
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia.
Ortoft G; Andreassen TT; Oxlund H
J Bone Miner Res; 1999 May; 14(5):710-21. PubMed ID: 10320519
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cortical and cancellous bone formation in glucocorticoid-treated OVX sheep.
Schorlemmer S; Ignatius A; Claes L; Augat P
Bone; 2005 Oct; 37(4):491-6. PubMed ID: 16046208
[TBL] [Abstract][Full Text] [Related]
15. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
Wang ML; Massie J; Perry A; Garfin SR; Kim CW
Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
[TBL] [Abstract][Full Text] [Related]
16. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
Brzóska MM; Moniuszko-Jakoniuk J
Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
[TBL] [Abstract][Full Text] [Related]
17. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
18. The effect of androstenedione/estrone supplementation on cortical and cancellous bone in the young intact female monkey: a model for the effects of polycystic ovarian disease on the skeleton?
Lundon KM; Jayo MJ; Register TC; Dumitriu M; Grynpas MD
Osteoporos Int; 2000; 11(9):778-89. PubMed ID: 11210841
[TBL] [Abstract][Full Text] [Related]
19. Reductions in bone turnover, mineral, and structure associated with mechanical properties of lumbar vertebra and femur in glucocorticoid-treated growing minipigs.
Ikeda S; Morishita Y; Tsutsumi H; Ito M; Shiraishi A; Arita S; Akahoshi S; Narusawa K; Nakamura T
Bone; 2003 Nov; 33(5):779-87. PubMed ID: 14623053
[TBL] [Abstract][Full Text] [Related]
20. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
